Screening for #lungcancer can help find cancers before they grow and spread, making treatment more manageable. Learn more about the latest screening guidelines from the American Cancer Society: acsjournals.onlinelibrary.wi…

Today we announced our receipt of a significant investment that will play a pivotal role in accelerating the commercialization of our FDA approved intraoperative molecular imaging agent. Learn more: prnewswire.com/news-releases… #SeeCancerInRealTime

Anyone with lungs can get #lungcancer. More awareness is needed to overcome the stigma and increase federal funding for critical lung cancer research. This #LCAM, empower yourself and your loved ones by learning the facts at lungevity.org/LCAM. #LCSM

Excited to attend the Southern Thoracic Surgical Association’s 70th Annual Meeting this week in Orlando. We look forward to sharing how our intraoperative molecular imaging agent can help surgeons #SeeCancerInRealTime.

Nearly 250,000 Americans will be diagnosed with #lungcancer, the leading cause of #cancer death in the U.S. It is encouraging to see @POTUS recognizing November as Lung Cancer Awareness Month again. We're proud to be part of the fight to end this disease. whitehouse.gov/briefing-room…

Meet the team: We thank our Vice President of Chemistry Manufacturing and Controls, Anne Fornicola, for her supervision of our product development and commercial supply chain. From manufacture of starting materials, to packaging of finished goods, we appreciate all that you do!

This #OvarianCancerAwarenessMonth, we’re honored that our technology has allowed for advancements in the detection of #ovariancancer. We are committed in our mission to illuminate cancer intraoperatively so it can be removed completely. Learn more: bit.ly/3QZ7Tqs

Meet the team: Accounting Manager Brittany Mitchell has a personal connection with #lungcancer that inspires her to help more patients through her work as an Accounting professional at On Target Laboratories. Thank you for all you do!

We are proud to share that our intraoperative molecular imaging agent has been awarded a new technology add-on payment that provides payment to hospitals utilizing our technology during ovarian and lung cancer surgery. Learn more: prnewswire.com/news-releases…

On this World Lung Cancer Day, we remain committed to supporting people living with #lungcancer like Terri Ann. We’re honored to be a part of the community and are steadfast in our mission to illuminate cancer intraoperatively so it can be removed completely. #WLCD